Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Diabetic Retinopathy - executive summary

Can J Ophthalmol. 2012 Apr;47(2):91-6. doi: 10.1016/j.jcjo.2012.01.022.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Canada / epidemiology
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / epidemiology
  • Diabetic Retinopathy / therapy*
  • Evidence-Based Medicine*
  • Humans
  • Incidence
  • Laser Coagulation
  • Ophthalmology / organization & administration*
  • Prevalence
  • Societies, Medical*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitrectomy

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A